NC
BSX icon

Northpointe Capital’s Boston Scientific BSX Stock Holding History

Northpointe Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-62,774
Closed -$2.41M – 91
2019
Q1 		$2.41M Buy
+62,774
New +$2.4M 0.76% 66
2015
Q1 		– Sell
-179,113
Closed -$2.37M – 237
2014
Q4 		$2.37M Buy
179,113
+15,583
+10% +$199K 0.29% 124
2014
Q3 		$1.93M Buy
163,530
+940
+0.6% +$11.8K 0.2% 143
2014
Q2 		$2.08M Buy
+162,590
New +$2.11M 0.2% 140

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Northpointe Capital's BSX Position: Q2 2019 in Review

Northpointe Capital sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 62,774 shares — an estimated $2.41M sold.

Northpointe Capital first reported a position in BSX in Q2 2014 and held it in 4 quarters. The position peaked at $2.41M in Q1 2019. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

  • Northpointe Capital reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
  • Northpointe Capital sold 62,774 Boston Scientific shares in Q2 2019, an estimated $2.41M.
  • Northpointe Capital first reported a position in Boston Scientific in Q2 2014 and held it in 4 quarters.
  • Northpointe Capital's Boston Scientific position peaked at $2.41M in Q1 2019.
  • 757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on Northpointe Capital's 13F filing for Q2 2019, filed 26 Jul 2019.